Last reviewed · How we verify
NCT05398107
Building Emotion Awareness and Mental Health (BEAM): Community Partnership With Family Dynamics
NA trial testing Experimental: Building Emotion Awareness and Mental Health (BEAM) in Depression, Anxiety in 80 participants. Completed in 30 December 2022.
30 July 2022
Quick facts
| Lead sponsor | University of Manitoba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 28 January 2022 |
| Primary completion | 30 July 2022 |
| Estimated completion | 30 December 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Experimental: Building Emotion Awareness and Mental Health (BEAM)
- Control: MoodMission
Conditions studied
- Depression, Anxiety — all drugs for Depression, Anxiety →
Sponsor
University of Manitoba
Who can join
18 and older, any sex, with Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Throughout the COVID-19 pandemic, postpartum depression and anxiety has increased dramatically. This is problematic as mothers in Manitoba must wait 12-18 months for therapeutic services. Children exposed to maternal mental illness in the first few years of life are at risk of negative lifelong adverse effects. Thus, the investigators of this project created and have tested The Building Emotion Awareness and Mental health (BEAM) program, which is an app-based mental health and parenting program for mothers of young children who are experiencing depression and/or anxiety. BEAM is now ready to be tested in partnership with an established community agency. This partnership will enable counsellors to provide expert-led mental health treatment to supplement and expand upon existing mental health services and will enable an established agency to address widespread unmet family mental health needs through the provision of mobile health (mHealth) content, training, and consultation. A two-arm pilot randomized controlled trial (RCT) with repeated measures will be used to evaluate the BEAM program compared to MoodMission (an evidence-based mHealth program) which will be the standard of care. Outcomes will be assessed to determine the effects of the BEAM program on reducing maternal mental health symptoms among a sample of 80 mothers who self-report moderate-to-severe symptoms of depression and/or anxiety (on the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7, respectively), meet criteria for a current major depressive episode and/or anxiety disorder (as determined on the Mini International Neuropsychiatric Interview) and have a child between the ages of 6 to 18 months old.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: protocol for a feasibility randomized controlled trial.
Joyce KM, Rioux C, MacKinnon AL, Katz LY, et al · · 2023 · cited 1× · PMID 36895006 · DOI 10.1186/s40814-023-01260-y -
Bridging the Gap: A Secondary Data Analysis of Implementation Outcomes and Symptom Trajectories of an eHealth Mental Health and Parenting Treatment Among Mothers With and Without At-Risk Substance Use.
Joyce KM, McHardy RJW, Kelly LE, Reynolds K, et al · · 2026 · PMID 41970406 · DOI 10.1177/29768357261438586 -
The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: Protocol for a feasibility randomized controlled trial
Joyce KM, Rioux C, MacKinnon AL, Katz LY, et al · · 2022 · DOI 10.21203/rs.3.rs-2235864/v1 -
The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: A study protocol for a pilot randomized controlled trial
Joyce KM, Rioux C, MacKinnon A, Katz L, et al · · 2022 · DOI 10.31234/osf.io/czt8h
Verify or expand the search:
- PubMed search for NCT05398107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression, Anxiety
Currently open trials in the same condition.
- NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
- NCT07280481 — Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress · NA · recruiting
- NCT07014852 — Integrating Inuit Knowledge Principles in Multi-Level Mental Health Clinical Trials · EARLY_PHASE1 · recruiting
- NCT07186816 — SUpport From PEeRs to Expand Access Study - Community · NA · recruiting
- NCT07091032 — Building Connections · NA · recruiting
Other University of Manitoba trials
Trials by the same sponsor.
- NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
- NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
- NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
- NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
- NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05398107 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
- Last refreshed: 22 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05398107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing